Artificial vascular graft
11648103 · 2023-05-16
Assignee
Inventors
- Bernhard Winkler (Bern, CH)
- Martin Grapow (Basel, CH)
- Friedrich Eckstein (Basel, CH)
- Aldo Ferrari (Zurich, CH)
- Dimos Poulikakos (Zollikon, CH)
- Simone Bottan (Zurich, CH)
- Maximilian Fischer (Munich, DE)
- Tobias Lendenmann (Zurich, CH)
Cpc classification
A61F2/90
HUMAN NECESSITIES
A61F2002/068
HUMAN NECESSITIES
A61F2002/072
HUMAN NECESSITIES
A61F2/062
HUMAN NECESSITIES
A61F2250/0051
HUMAN NECESSITIES
A61F2210/0014
HUMAN NECESSITIES
A61F2002/0086
HUMAN NECESSITIES
International classification
Abstract
The invention relates to an artificial vascular graft comprising a primary scaffold structure encompassing an inner space of the artificial vascular graft, said primary scaffold structure having an inner surface facing towards said inner space and an outer surface facing away from said inner space, a coating on said inner surface, wherein a plurality of grooves is comprised in said coating of said inner surface. The primary scaffold structure comprises further a coating on said outer surface. The primary scaffold structure and the coating on said inner surface and on said outer surface are d designed in such a way that cells, in particular progenitor cells, can migrate from the periphery of said artificial vascular graft through said outer surface of said coating, said primary scaffold structure and said inner surface to said inner space, if the artificial vascular graft is used as intended. The invention relates further to a method for providing said graft.
Claims
1. An artificial vascular graft (1) comprising a primary scaffold structure (2) encompassing an inner space (8) of the artificial vascular graft (1), said primary scaffold structure (2) having a. an inner surface (21) facing towards said inner space (8) and b. an outer surface (20) facing away from said inner space (8) and c. a coating (3) on said inner surface (21) and on said outer surface (20) characterized in that a plurality of grooves (4) is comprised in said coating (3) of said inner surface (21); wherein said primary scaffold structure (2) comprises holes or a mesh structure so that progenitor cells can migrate through an outer surface of said coating (3), said primary scaffold structure (2) and said inner surface of said coating (3) to said inner space (8), and wherein the coating (3) is a cellulose coating comprising a three-dimensional structure pattern of interconnected fibers.
2. The artificial vascular graft according to claim 1, wherein the primary scaffold structure (2) and/or the coating (3) is characterized by a tubular shape.
3. The artificial vascular graft according to claim 2, characterized in that the primary scaffold structure (2) has an outer diameter (X) in the range of about 1.5 mm to 40 mm, and the coating (3) has an inner diameter (Y) in the range of about 1 mm to 35 mm.
4. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) and/or the the coating (3) is characterized by a compliance in the range of 400 to 1000%/ 2.93 kPa.
5. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) and/or the coating (3) is able to recoil to an original state after a symmetrical, radial expansion perpendicular to thae longitudinal axis of the artificial vascular graft (1), wherein said radial expansion is in the range of 5% to 40% with respect to an original outer diameter (X) of the primary scaffold structure (2) or an original inner diameter (Y) of the coating (3).
6. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) comprises a metal or metal alloy.
7. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) comprises a shape memory alloy.
8. The artificial vascular graft according to claim 1, characterized in that the three-dimensional structure pattern comprisesin the form of pores with a diameter of 50 nm to 500 nm.
9. The artificial vascular graft according to claim 1, characterized in that the coating (3) comprises an inner coating surface (31), which is facing towards the inner space (8) of the artificial vascular graft (1) and a second coating (7) on said inner coating surface (31).
10. The artificial vascular graft according to claim 1, characterized in that essentially each groove of the plurality of grooves (4) has a width (W) of 0.5 μm to 200 μm.
11. The artificial vascular graft according to claim 1, characterized in that the coating (3) comprises an inner coating surface (31), which is facing towards the inner space (8) of the artificial vascular graft (1) and a second coating (7) comprising Collagen IV on said inner coating surface (31).
12. The artificial vascular graft according to claim 1, characterized in that essentially each groove of the plurality of grooves (4) has a width (W) of 1 μm to 50 μm.
13. The artificial vascular graft according to claim 1, characterized in that essentially each groove of the plurality of grooves (4) has a width (W) of 2 μm to 5 μm.
14. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) has an outer diameter (X) in the range of about 1.5 mm to 15 mm and the coating (3) has an inner diameter (Y) in the range of about 3.5 mm to 5 mm.
15. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) and/or the coating (3) is characterized by a compliance in the range of 600 to 800%/ 2.93 kPa.
16. The artificial vascular graft according to claim 1, characterized in that the primary scaffold structure (2) and/or the coating (3) is able to recoil to an original state after a symmetrical, radial expansion perpendicular to the longitudinal axis of the artificial vascular graft (1), wherein said radial expansion is in the range of 15% to 20% with respect to an original outer diameter (X) of the primary scaffold structure (2) or an original inner diameter (Y) of the coating (3).
17. The artificial vascular graft according to claim 1, wherein the coating (3) consists of cellulose in the three-dimensional structure pattern of interconnected fibers.
Description
FIGURE LEGENDS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
REFERENCE LIST
(8) 1 vascular graft 2 primary scaffold structure 20 outer surface of the primary scaffold structure 21 inner surface of the primary scaffold structure 3 coating 30 outer coating surface of the coating 31 inner coating surface of the coating 4 grooves 7 second coating, 71 inner second coating surface of the second coating 8 inner space of the artificial vascular graft A thickness of the primary scaffold structure B inner thickness of the coating C outer thickness of the coating D depth of the grooves N distance between neighboring grooves L lower width of the grooves U upper width of the grooves W maximal width of the grooves X outer diameter of the primary scaffold structure Y inner diameter of the coating
FIGURES AND EXAMPLES
(9)
(10) The artificial vascular graft 1 comprises a primary scaffold structure 2, which encompasses an inner space 8 of the artificial vascular graft 1. The primary scaffold structure 2 has an inner surface 21 facing towards the inner space 8 and an outer surface 20 facing away from the inner space 8. The artificial vascular graft 1 comprises further a coating 3 situated on the inner surface 21 of the primary scaffold structure 2. The coating 3 comprises further an inner coating surface 31 facing towards the inner space 8 of the artificial vascular graft 1. Additionally, the artificial vascular graft 1 comprises a plurality of grooves (not shown due to reasons of clarity; concerning the plurality of grooves on the inner coating surface 31 of the coating 3 reference is made to
(11) The primary scaffold structure 2 and the coating 3 comprise each a symmetrical, tubular shape with identical diameters throughout the tubular artificial vascular graft 1.
(12) The primary scaffold structure 2 comprises a tubular shape with an outer diameter X of about 3 mm for use as a small-size diameter artificial vascular graft 1. The outer diameter X is the maximal distance of two points situated on the outer surface 20 of the primary scaffold structure 2, measured through the center of the tubular primary scaffold structure 2 and in the plane, which extends vertical to the longitudinal extension direction of primary scaffold structure 2, whereby the outer diameter X is depicted in
(13) The primary scaffold structure 2 comprises an inert, sterile, anti-thrombogenic and semipermeable polymer material. Reference is made to the above discussed polymer materials.
(14) The coating 3 comprises a tubular shape with an inner diameter Y of about 2 mm. The inner diameter Y is the maximal distance of two points situated on the inner coating surface 31 of the tubular coating 3, measured through the center of the tubular coating 3 and in the plane, which extends vertical to the longitudinal extension direction of tubular coating 3. The inner thickness B of the coating 3 (the difference between the inner diameter of the primary scaffold structure 2 and the inner diameter Y of the coating 3) is about 0.8 mm. Concerning the inner diameter Y and the inner thickness B of the coating 3, all the previously discussed values may be employed.
(15) The coating 3 consists of an inert, sterile, anti-thrombogenic and semipermeable polymer material. Reference is made to the above discussed polymer materials.
(16) The primary scaffold structure 2 and the coating 3 comprise a compliance of 600%/2.93 kPa (22 mm Hg), a flexibility of 15% and a burst pressure higher than 133.32 kPa. Other materials with a compliance and flexibility according to the above discussed characteristics may be applied.
(17) Therefore, the primary scaffold structure 2 and the coating 3 comprise similar mechanical properties as the native counterpart and provide a response to physiological changes by means of adequate vasoconstriction and relaxation, if it is used as intended. They function without undue bulging or aggravated mismatching phenomena leading to graft failure. Concerning the characteristics of the grooves 4, reference is made to the discussion of
(18)
(19) The artificial vascular graft 1 comprises a tubular primary scaffold structure 2, which encompasses an inner space 8 of the artificial vascular graft 1. The maximal width of the grooves primary scaffold structure 2 has an inner surface 21 facing towards the inner space 8 and an outer surface 20 facing away from the inner space 8. The artificial vascular graft 8 comprises further a coating 3, which encloses the primary scaffold structure 2. The coating 3 comprises an inner coating surface 31 facing towards the inner space 8 of the artificial vascular graft 1 and an outer coating surface 30 facing away from the inner space 8 of the artificial vascular graft 1.
(20) Additionally, the artificial vascular graft 1 comprises a plurality of grooves 4 (which will be shown in
(21) The primary scaffold structure 2 and the coating 3 comprise each a symmetrical tubular structure with identical diameters throughout the tubular artificial vascular graft 1.
(22) The primary scaffold structure 2 comprises a tubular shape with an outer diameter X (as defined previously) of about 4 mm for use as a small-size diameter artificial vascular graft 1, whereby the outer diameter X is depicted in
(23) The coating 3 comprises a tubular shape with an inner diameter Y (as defined previously) of about 2.5 mm. The inner thickness B (the difference between the inner diameter of the primary scaffold structure 2 and the inner diameter Y of the coating 3) and the outer thickness C of the coating 3 (the difference between the outer diameter X of the primary scaffold structure 2 and the outer diameter of the coating 3) is about 0.8 mm. Different values of the inner diameter Y, inner thickness B and outer thickness C of the coating 3 may be applied.
(24) The primary scaffold structure 2 consists of a Nitinol-mesh with flexibility of 20%, compliance in the range of 700%/2.93 kPa (22 mm Hg) and burst pressure higher than 133.32 kPa. The Nitinol mesh comprises a wire mesh structure, whereby the maximal distance between neighboring wires ranges from about 35 μm to 50 μm. Thus, the wire mesh structure provides “holes” in the surface with an area of up to 2 500 μm.sup.2. Other materials or other wires with different characteristics, as previously discussed, may be applied.
(25) The coating 3 consists of an inert, sterile, anti-thrombogenic and semipermeable cellulose, derived from the bacteria Acetobacter. The coating 3 comprise further a compliance of 700%/2.93 kPa, a flexibility of 20% and a burst pressure higher than 133.32 kPa. Other materials with a compliance and flexibility according to the above discussed characteristics may be applied. Thus, the coating material is compatible for every patient and there is no need for additional anticoagulation and the artificial vascular graft is able to recoil in order to prevent aneurysm formation and exhibits a physiological compliance comparable to a native vessel in order to withstand hemodynamic pressure changes without failure, if the artificial vascular graft is used as intended.
(26) The flexibility of the primary scaffold structure 2 and the coating 3 allow a shear stress of more than 2.5 Pa, if the artificial vascular graft is used as intended. Reference is made to the previous discussion for further details.
(27) Therefore, the primary scaffold structure 2 and the coating 3 comprise similar mechanical properties as the native counterpart and provide a response to physiological changes by means of adequate vasoconstriction and relaxation, if it is used as intended. They function without undue bulging or aggravated mismatching phenomena leading to graft failure.
(28) Furthermore, the cellulose material of the coating 3 reaches through the “holes” of the mesh structure of the primary scaffold structure 2 allowing a strong connection between the primary scaffold structure 2 and the coating 3. Thus, providing a necessary stability after a potential cutting of the artificial vascular graft 1 (no parts of the mesh of the primary scaffold structure will come in contact with living tissue, due to the coating 3, in which the primary scaffold structure 2 is completely embedded).
(29) Additionally, the mesh structure of the primary scaffold structure 2 and the semipermeable cellulose material of the coating 3 allow, if the graft is used as intended, only a migration of a specific type of cells and gases from the outside of the artificial vascular graft 1 to the inner space 8 of the artificial vascular graft 1. Particularly O.sub.2 and CO.sub.2, vascular growth factors, all humoral agents, progenitor cells capable of differentiating towards endothelial lineages and macrophages, are allowed to migrate through the primary scaffold structure 2 and the coating 3 to the inner coating surface 31 of the coating 3, whereby the coating 3 remains impermeable for the remaining substances of blood. Thus, the coating 3 functions as a selective barrier inside the artificial vascular graft 1.
(30) Furthermore, the inner coating surface 31 of the coating 3 comprises a plurality of grooves 4 (
(31) The plurality of grooves 4 on the inner coating surface 31 of the coating 3 have a maximal width W of about 5 μm. The maximal width W of the grooves 4 is the maximal distance between one side of the groove 4 and the neighboring side of the same groove 4, measured transverse to the longitudinal extension direction of the sides. Furthermore, the depth D of the grooves 4, which is the distance from the circumference of the inner coating surface 31 of the coating 3 to the bottom of the groove 4, is about 2 μm. The distance N between neighboring grooves is about 1 μm. The distance N between neighboring grooves is the distance between one side of a groove and the neighboring side of a neighboring groove, measured along the circumference of the inner coating surface 31 of the coating 3.
(32) If the artificial vascular graft 1 is used as intended, progenitor cells and endothelial cells (in a small amount) are captured at the inner coating surface 31 of the coating 3. Progenitor cells differentiate to endothelial or smooth muscle cells depending on the conditions inside the artificial vascular graft 1. Two of the main conditions are the shear stress on a progenitor cell and the amount of turbulent flow inside the artificial vascular graft 1. Reference is made to the previous discussion for further details.
(33) The alignment and the form of the groves 4 in the longitudinal direction (in other words in the direction of the blood flow) prevents a turbulent flow inside the artificial vascular graft 1, in particular a turbulent flow, which is directed essentially crosswise to the grooves 4.
(34) In general, the higher the shear stress and the lower the turbulent flow, the higher the chances that a progenitor cell will differentiate to an endothelial cell. On the other hand, the more turbulent flow resides inside the artificial vascular graft 1 and the lower the shear stress on the progenitor cells, the higher the chances that the differentiation to smooth muscle cells occurs. Given the combination of the near laminar flow and the shear stress on the progenitor cells at the luminal position or near the luminal position, the progenitor cells in these positions will differentiate to endothelial cells, whereby the progenitor cells near the coating 3 will differentiate to smooth muscle cells, due to the lower shear stress.
(35) The artificial vascular graft 1 of
(36) By the in-vivo capturing and/or differentiation of endothelial cells a functional endothelium is provided in the luminal position with anti-thrombogenic properties. Due to tight intercellular connections, the provided endothelium works as a semi-selective barrier between the lumen of the artificial vascular graft and surrounding tissue, controlling the passage of materials and the transit of white blood cells into and out of the bloodstream. The artificial vascular graft 1 could be used without a time delay and is compatible for every patient and comprise similar blood vessel qualities as a human blood vessel, including an appropriate physiological compliance, flexibility and burst pressure in order to withstand hemodynamic pressure changes without failure and provides an appropriate response to physiological changes and anti-thrombogenic and non-immunogenic properties. The artificial vascular graft 1 comprises an unproblematic storage and rapid availability.
(37)
(38) The main difference is, that the artificial vascular graft 1 of
(39) Collagen IV as a second coating 7 material allows for, if the artificial vascular graft is used as intended, a high capture rate of endothelial cells and progenitor cells on the inner second coating surface 71 of the second coating 7 and a differentiation rate of progenitor cells to endothelial cells in a rate of essentially 100%, as discussed above. Reference is made to the previously discussed properties concerning the plurality of grooves.
(40)
(41)
(42)
(43)
(44)